Cargando…
An Algorithm for the Preclinical Screening of Anticancer Drugs Effective against Brain Tumors
The anticancer drugs screening program is a long and expensive process. It is estimated that only 5% of drugs entering clinical trials are approved by the FDA. Moreover, many of the drugs that enter clinical trials are often of limited use in clinical practice, and most cancers remain untreatable. B...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Scholarly Research Network
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398605/ https://www.ncbi.nlm.nih.gov/pubmed/22830045 http://dx.doi.org/10.5402/2012/513580 |